Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered. Based on new findings in Chinese men, the researchers are urging similar studies in other groups to advance precision medicine and better tailor treatments. An international team of researchers co-led by UVA's Hui Li, PhD, looked at what are known as "chimeric RNA" in Chinese men and found both similarities and differences to those seen in Western men. These RNAs can contribute to the growth of cancer and are widely used as both indicators of...